Inventor · disambiguated record
Eliezer Bahar
Also filed as: BAHAR ELIEZER
12 granted patents·10 pending applications·413 citations·filing 1995–2023
93Inventor score
Top patents by PatentIndex Score
22 records- 0197US5877218ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Mar 2, 1999·153 cites·19 claims
- 0296US7619117B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Nov 17, 2009·39 cites·11 claims
- 0395US5639913AMethod for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1996·Granted Jun 17, 1997·63 cites·38 claims
- 0494US7598420B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Oct 6, 2009·46 cites·20 claims
- 0594US7572834B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2006·Granted Aug 11, 2009·49 cites·12 claims
- 0691US6271263B1Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Aug 7, 2001·35 cites·21 claims
- 0790US7375249B2Process for the synthesis of enantiomeric indanylamine derivativesTEVA PHARMA·Filed 2006·Granted May 20, 2008·13 cites·24 claims
- 0875US7476757B2Process for the synthesis of enantiomeric indanylamine derivativesTEVA PHARMA·Filed 2008·Granted Jan 13, 2009·2 cites·6 claims
- 0975US7335685B2Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereofTEVA PHARMA·Filed 2006·Granted Feb 26, 2008·2 cites·25 claims
- 1071US6218566B1Process for manufacturing of L-DOPA ethyl esterTEVA PHARMA·Filed 1999·Granted Apr 17, 2001·11 cites·28 claims
- 1164US2025250233A1Processes and intermediates for the preparation of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 1260US2015045445A13-keto-n-propargyl-1-aminoindanFRENKEL ANTON·Filed 2014·Application pending·0 cites
- 1355US2009275653A1Polymorphic forms of ladostigil tartrateTEVA PHARMACEUTICAL IND USA IN·Filed 2009·Application pending·0 cites
- 1450US2011152381A13-keto-n-propargyl-1-aminoindanFRENKEL ANTON·Filed 2010·Application pending·0 cites
- 1549US2007088082A1Polymorphic forms of ladostigil tartrateARONHIME JUDITH·Filed 2006·Application pending·0 cites
- 1646US9346746B2R(+)-N-formyl-propargyl-aminoindanTEVA PHARMA·Filed 2012·Granted May 24, 2016·0 cites·24 claims
- 1745US9339469B2R(+)-N-methyl-propargyl-aminoindanTEVA PHARMA·Filed 2012·Granted May 17, 2016·0 cites·21 claims
- 1845US2012101168A1Deuterium enriched rasagilineBAHAR ELIEZER·Filed 2011·Application pending·0 cites
- 1942US2013089611A1Rasagiline citramideTEVA PHARMA·Filed 2012·Application pending·0 cites
- 2042US2007093549A1Methods for preparation of ladostigil tartrate crystalline form A1ARONHIME JUDITH·Filed 2006·Application pending·0 cites
- 2141US2002026069A1Process for manufacture of L-DOPA ethyl esterFiled 2001·Application pending·0 cites
- 2237US2003135065A1Process for the production of L-DOPA ethyl esterFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →